Cresco Labs Inc. (CRLBF)
OTCMKTS · Delayed Price · Currency is USD
1.240
-0.040 (-3.13%)
At close: Jan 9, 2026
Cresco Labs Revenue
Cresco Labs had revenue of $164.91M in the quarter ending September 30, 2025, a decrease of -8.27%. This brings the company's revenue in the last twelve months to $661.62M, down -9.79% year-over-year. In the year 2024, Cresco Labs had annual revenue of $715.76M, down -5.33%.
Revenue (ttm)
661.62M
Revenue Growth
-9.79%
P/S Ratio
0.69
Revenue / Employee
228.14K
Employees
2,900
Market Cap
455.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 715.76M | -40.30M | -5.33% |
| Dec 31, 2023 | 756.06M | -68.87M | -8.35% |
| Dec 31, 2022 | 824.93M | 19.25M | 2.39% |
| Dec 31, 2021 | 805.68M | 342.60M | 73.98% |
| Dec 31, 2020 | 463.08M | 338.89M | 272.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |
Cresco Labs News
- 1 day ago - Cresco Labs Opens Sunnyside Tamarac, Expanding Patient Access in Broward County, Florida - Business Wire
- 8 days ago - Top Marijuana Stocks To Buy In 2026 That Could See Big Gains - MarijuanaStocks
- 15 days ago - 3 Marijuana Stocks To Watch In 2026 - MarijuanaStocks
- 20 days ago - Cresco Labs Benefits From Cannabis Rescheduling - Seeking Alpha
- 23 days ago - Cresco Labs CEO: Rescheduling Marks Historic Shift for Cannabis Industry - Business Wire
- 24 days ago - Pot stocks pop on Schedule 3 hopes: Tilray Brands, Trulieve Cannabis, Cresco Labs: How high will they go? - Fast Company
- 26 days ago - 3 Marijuana Stocks For Your 2026 Watchlist - MarijuanaStocks
- 4 weeks ago - U.S. Marijuana Stocks Positioned for Growth as Reform Discussions Continue - MarijuanaStocks